Population
Patients with arrhythmogenic right ventricular dysplasia
Design
Review
Authors
Loading...
Standard ARVD care pathways remain appropriate; leaves open need for prospective genetic and device trials.
Arrhythmogenic right ventricular dysplasia is a genetic condition linked to chromosome 14, characterized by specific ECG changes and managed with antiarrhythmics, ablation, ICDs, or transplantation.
G Fontaine (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: